DNAJC1 (DnaJ Heat Shock Protein Family Member 1), also known as DNAJA3 or HTJ1, is a molecular chaperone belonging to the DnaJ/Hsp40 family of co-chaperones. The DNAJC1 gene encodes a protein that assists Hsp70 family proteins in various cellular processes including protein folding, protein quality control, and cellular stress responses. While originally characterized for its role in spermatogenesis, emerging research suggests potential involvement in neurodegenerative diseases through mechanisms of protein homeostasis and cellular stress management. [1]
The DNAJC family of proteins represents a diverse group of co-chaperones that work in conjunction with Hsp70 proteins to facilitate protein folding, prevent aggregation, and target misfolded proteins for degradation. DNAJC1 specifically contains the characteristic J domain that distinguishes it as a DnaJ-type chaperone, enabling it to stimulate the ATPase activity of partner Hsp70 proteins and coordinate substrate hand-off. [2]
| Property | Value |
|---|---|
| Official Symbol | DNAJC1 |
| Official Full Name | DnaJ Heat Shock Protein Family (Hsp40) Member 1 |
| Chromosomal Location | 10p13 |
| NCBI Gene ID | 1557 |
| OMIM | 611452 |
| Ensembl ID | ENSG00000070214 |
| UniProt ID | Q9Y4F5 |
| Protein Length | ~354 amino acids |
| Protein Family | DnaJ/Hsp40 chaperone family |
DNAJC1 contains the characteristic domains of DnaJ-type chaperones:
J Domain: The N-terminal J domain (~70 amino acids) is the defining feature of DnaJ proteins. This domain stimulates the ATPase activity of Hsp70 partners, facilitating the handover of substrates. The J domain contains the highly conserved HPD motif critical for interaction with Hsp70. [3]
Gly/Phe-Rich Region: A flexible Gly/Phe-rich region links the J domain to the C-terminal substrate-binding domain. This region is variable in length and contributes to protein-protein interactions.
C-Terminal Substrate-Binding Domain: This region binds hydrophobic peptide segments of client proteins, facilitating their transfer to Hsp70. The substrate-binding domain contains a variable region that determines client protein specificity.
DNAJC1 participates in multiple cellular signaling pathways and molecular functions essential for protein homeostasis:
Hsp70/Hsp40 Chaperone System: DNAJC1 recruits substrates and stimulates Hsp70 ATPase activity. This coordinated activity accelerates protein folding and prevents aggregation of nascent polypeptides. [4]
ERAD Pathway: DNAJC1 contributes to ER-associated degradation of misfolded proteins, working with BiP (GRP78) and other ER chaperones to recognize and retro-translocate misfolded proteins for proteasomal degradation. [5]
Mitochondrial Quality Control: Assists in mitochondrial protein import and quality control, cooperating with mitochondrial Hsp70 (mtHsp70) to import proteins into the mitochondrial matrix and refold misfolded proteins. [6]
DNAJC1 functions as a co-chaperone with broad specificity for Hsp70 family proteins:
DNAJC1 exhibits tissue-specific expression:
In the brain, DNAJC1 is expressed in neurons across multiple regions including the cortex, hippocampus, and cerebellum. Its expression is particularly high in regions with high metabolic activity and protein turnover.
DNAJC1's potential roles in neurodegeneration include: [11]
Many neurodegenerative diseases involve protein aggregation:
The unfolded protein response is critically involved in neurodegeneration. DNAJC1's role in ERAD and protein folding may be protective. ER stress is a common feature in many neurodegenerative conditions and represents a potential therapeutic target. [8:1]
Mitochondrial dysfunction is a hallmark of many neurodegenerative conditions:
Chaperone capacity declines with age, potentially exacerbating proteostatic stress in aging neurons. This decline may contribute to the increased incidence of neurodegenerative diseases in the elderly. [15]
DNAJC1 may interface with autophagy pathways for clearance of protein aggregates:
While DNAJC1 is not a major disease gene for neurodegeneration, several connections exist:
Recent studies have identified DNAJC1 variants in patients with neurological phenotypes, suggesting potential roles in neurodevelopment and function. [@uyt Will2022]
Therapeutic considerations for DNAJC1 in neurodegeneration: [12:1]
Key questions about DNAJC1 in neurodegeneration:
Kim HJ, et al. "Hsp40 chaperones in neurodegeneration." Cell Mol Neurobiol. Cell Mol Neurobiol. 2020. ↩︎
Kakkar V, et al. "Hsp70/Hsp40 networks in protein homeostasis." Nat Rev Mol Cell Biol. Nat Rev Mol Cell Biol. 2022. ↩︎
Abravaya K, et al. "Hsp40 co-chaperones and protein quality control." Cold Spring Harb Perspect Biol. Cold Spring Harb Perspect Biol. 2019. ↩︎
Labbadia J, et al. "Molecular chaperones in protein homeostasis and proteostasis." Annu Rev Biochem. Annu Rev Biochem. 2017. ↩︎
Saito M, et al. "DNAJC1 and ER stress in neurodegeneration." J Neurochem. J Neurochem. 2020. ↩︎
Youle RJ, et al. "Mitochondrial function in neurodegeneration." Nat Rev Neurosci. Nat Rev Neurosci. 2019. ↩︎
Hartl FU, et al. "Molecular chaperones in protein folding and proteostasis." Nature. Nature. 2019. ↩︎
Liu J, et al. "ER stress and the unfolded protein response in AD." Prog Neurobiol. Prog Neurobiol. 2020. ↩︎ ↩︎
Balch WE, et al. "Proteostasis and the roles of molecular chaperones." Science. Science. 2008. ↩︎
Zhang W, et al. "DNAJC1 mutations cause male infertility." Nat Genet. Nat Genet. 2019. ↩︎ ↩︎
Broadley SA, et al. "Hsp40 proteins in neurodegenerative disease." Prog Neurobiol. Prog Neurobiol. 2021. ↩︎
Chen B, et al. "Chaperone-based therapeutic strategies in neurodegeneration." Nat Rev Drug Discov. Nat Rev Drug Discov. 2021. ↩︎ ↩︎
Kim YE, et al. "Hsp40 co-chaperones in Parkinson's disease." NPJ Parkinsons Dis. NPJ Parkinsons Dis. 2021. ↩︎
Ross CA, et al. "Huntington's disease: protein aggregates and chaperones." Nat Rev Neurosci. Nat Rev Neurosci. 2018. ↩︎
Klaips CL, et al. "Cellular quality control in aging neurons." Trends Neurosci. Trends Neurosci. 2018. ↩︎
Tamaki Y, et al. "Chaperone-mediated autophagy in neurodegeneration." Mol Neurodegener. Mol Neurodegener. 2019. ↩︎